This inventor holds 1 USPTO granted patent. Top assignee: Samyang Corporation. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Heenam Park: Innovator in Colonic Drug Delivery
Introduction
Heenam Park is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. His innovative work focuses on enhancing the effectiveness of drug delivery to the colon.
Latest Patents
Heenam Park holds a patent for a composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides. This colonic drug delivery composition includes a first polysaccharide and a second polysaccharide, both of which are degradable by colonic enzymes. The composition is mixed at an environmental pH of about 7 or above, without the use of a cross-linking agent. The patent also describes a colon-selective pharmaceutical composition and dosage form for the oral delivery of a drug, diagnostic reagent, or a mixture thereof. The method of preparing this colonic drug delivery composition is also disclosed in the patent.
Career Highlights
Heenam Park is associated with Samyang Corporation, where he continues to advance his research in pharmaceutical formulations. His work has the potential to significantly improve therapeutic outcomes for patients requiring targeted drug delivery to the colon.
Collaborations
Heenam Park collaborates with talented colleagues, including Sujung Lee and In Park, who contribute to his research endeavors.
Conclusion
Heenam Park's innovative approach to colonic drug delivery exemplifies the importance of research in pharmaceutical sciences. His contributions are paving the way for more effective treatment options in the future.